Indian Drug Makers Move To Novel Drug Delivery Systems

India is expected to ride the drug industry trend toward new ways to deliver new drugs to patients, a growing segment of the pharmaceutical industry. Many Indian drug makers are working on novel drug discovery systems, already comprising nearly six percent of the Indian market. Revenues from NDDS products are expected to generate 29 percent annual growth in India, compared with 17 percent by the industry at large. Much of the new focus by drug makers results from a shrinking number of innovative drugs coming on the market at the same time blockbuster drugs lose their patent protections. (Click here for more